WEWC Impact

• $45.5 million to The Campbell Family Institute for Breast Cancer Research led by Dr. Tak Mak, with 11 Principal Investigators and over 130 staff.
• $5.2 million to purchase cutting edge research equipment and support breast cancer research activities in the PMH research expansion at MaRS (Medical and Related Science).
• $3 million to create The Weekend to End Breast Cancer Chair in Breast Cancer Research, held by Dr. Tak Mak, a world renowned cancer research scientist.
• $1.5 million to the Walker Innovation Program, which supports researchers and new ideas that have the potential for advancing scientific knowledge of breast cancer.
• $1.3 million to support Dr. Norman Boyd’s research into breast cancer prevention, focusing on the understanding of mammographic density as a risk factor.
• $1.8 million to support the Mass Spectrometer Program
• Funding to support Dr. Pamela Ohashi’s research into T-cell activation and immunotherapy.

• $3.9 million toward a comprehensive breast imaging program and the purchase of a breast MRI and digital mammography machine.
• $3 million toward a newly revamped and re-designed M. Lau Breast Centre that provides complete care for breast cancer patients.
• $2.4 million to support clinical trials for breast cancer patients, and $5000,000 for a fellowship program.
• $2 million to support an extensive Tumour Bank, database maintenance and pathology renovations.
• $1.3 million to support Dr. David McCready’s rapid diagnosis pilot study, which is now The Gattuso Rapid Diagnostic Centre and sees up to 750 patients a year.
• $550,000 to support the clinical trial of intraoperative radiation therapy, led by Dr. David McCready and Dr. Anthony Fyles.
• $250,000 toward the design and creation of the new Conway Chemotherapy and Transfusion Centre, the largest centre of its kind in North America.
• $400,000 to support the surgical robotics program for gynecological cancer patients.
• $160,000 toward the Familial Ovarian Cancer Clinic, which now also provides genetic counselling for breast cancer patients.
• $2.2 million for other clinical enhancements and genetics research programs.

• $8.9 million for the establishment and continued support of the first in-hospital Survivorship Clinic and Program in Canada. This includes ELLICSR, a 12,000-square-foot innovative research centre, led by Dr. Pamela Catton, and www.caringvoices.ca, an award-winning online community for survivors and their families.
• $1 million to provide reconstructive breast surgery for women who have had breast cancer.

We Are the Change: A Focus on Women's Cancers

On May 16th, The Zoomer Report presented "We Are the Change: A Focus on Women's Cancers". Four leading doctors and researchers from The Princess Margaret spoke about advances in cancer research, discoveries made at The Princess Margaret, the benefits and impact of the HPV vaccine, risks related to breast density and the groundbreaking Survivorship Program.

Please see below the videos from the evening's event.